Cetera Investment Advisers - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 18 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cetera Investment Advisers ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$90,000
-17.4%
45,025
+11.8%
0.00%
-50.0%
Q1 2021$109,000
-9.9%
40,2750.0%0.00%0.0%
Q4 2020$121,000
+45.8%
40,275
+140.2%
0.00%
-71.4%
Q3 2020$83,00016,7650.01%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 80,094$104,0000.08%
PERKINS CAPITAL MANAGEMENT INC 51,178$67,0000.04%
HATTON CONSULTING, INC. 27,195$35,0000.03%
GSA CAPITAL PARTNERS LLP 78,687$102,0000.01%
CRA Financial Services, LLC 19,957$26,0000.01%
Virtu Financial LLC 25,507$33,0000.00%
WEDBUSH SECURITIES INC 32,228$42,0000.00%
TWO SIGMA SECURITIES, LLC 15,347$20,0000.00%
UBS Group AG 13,118$17,0000.00%
US BANCORP \DE\ 9,047$12,0000.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders